Artal International S.C.A.

Insider Reports History

Entity
Individual
Location
Valley Park, 44, Rue De La Vallee, Luxembourg, Luxembourg
Signature
ARTAL INTERNATIONAL S.C.A. By: Artal International Management S.A., its Managing Partner By: /s/ Pierre Claudel Name: Pierre Claudel Title: Managing Director
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Artal International S.C.A.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CAVA GROUP, INC. Director, 10%+ Owner Common Stock 17.5M $2.04B $116.36 Aug 26, 2024 Direct
LEXICON PHARMACEUTICALS, INC. Director, 10%+ Owner Common Stock 136M $357M $2.62 May 10, 2024 Indirect
LEXICON PHARMACEUTICALS, INC. Director, 10%+ Owner Series A Convertible Preferred Stock 0 $0 $108.50 May 10, 2024 Indirect

Insider Reports Filed by Artal International S.C.A.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CAVA CAVA GROUP, INC. Aug 26, 2024 1 -$698M 4 Aug 28, 2024 Director, 10%+ Owner
CAVA CAVA GROUP, INC. Jun 5, 2024 1 -$262M 4 Jun 7, 2024 Director, 10%+ Owner
LXRX LEXICON PHARMACEUTICALS, INC. May 10, 2024 3 $125M 4 May 14, 2024 Director, 10%+ Owner
CAVA CAVA GROUP, INC. Mar 21, 2024 1 -$133M 4 Mar 25, 2024 Director, 10%+ Owner
LXRX LEXICON PHARMACEUTICALS, INC. Mar 13, 2024 1 $125M 4 Mar 13, 2024 Director, 10%+ Owner
CAVA CAVA GROUP, INC. Feb 27, 2024 1 -$188M 4 Feb 29, 2024 Director, 10%+ Owner
CAVA CAVA GROUP, INC. Jun 20, 2023 12 $0 4 Jun 22, 2023 Director, 10%+ Owner
CAVA CAVA GROUP, INC. Jun 15, 2023 0 $0 3 Jun 15, 2023 Director, 10%+ Owner
LXRX LEXICON PHARMACEUTICALS, INC. Jun 5, 2023 1 $72.2M 4 Jun 5, 2023 Director, 10%+ Owner
LXRX LEXICON PHARMACEUTICALS, INC. Aug 5, 2022 1 $6.07M 4 Aug 9, 2022 Director, 10%+ Owner
LXRX LEXICON PHARMACEUTICALS, INC. Aug 1, 2022 1 $40.4M 4 Aug 1, 2022 Director, 10%+ Owner